儿童造血干细胞移植后发生重度非感染性肺部并发症影响因素的病例对照研究OA
Influencing factors of severe non-infectious pulmonary complications after hematopoietic stem cell transplantation in children:a case-control study
背景 儿童造血干细胞移植(hematopoietic stem cell transplantation,HSCT)后非感染性肺部并发症(non-infectious pulmonary complications,NIPC)起病隐匿,早期诊断困难,发展至重度后疗效差.目的 探究儿童HSCT后发生重度NIPC的危险因素,为临床诊断和管理提供参考.设计 病例对照研究.方法 纳入2020年5月1日至2023年12月31日中山大学孙逸仙纪念医院儿童医学中心接受HSCT后发生NIPC,年龄≤16岁,且行支气管肺泡灌洗液(bronchoalveolar lavage fluid,BALF)免疫学检查的患儿.排除因药物或其他原因所致NIPC以及肺功能检查质量欠佳的患儿.根据诊断NIPC时通气功能障碍程度分为轻中度组和重度组,收集患儿一般信息、移植相关资料、BALF免疫学指标等临床资料,通过单因素和多因素分析儿童HSCT后出现重度NIPC结局的影响因素.主要结局指标 HSCT后出现重度NIPC结局的影响因素.结果 最终纳入25例HSCT治疗后发生NIPC的患儿,其中轻中度组14例(56.0%),重度组11例(44.0%).22例(88.0%)表现为闭塞性细支气管炎综合征,3例(12.0%)表现为肺纤维化,4例(16.0%)合并气胸、纵隔或皮下气肿.单因素分析显示,轻中度组患儿BALF中白细胞介素(interleukin,IL)-8、IL-17A及CD8+T淋巴细胞水平均低于重度组(P<0.05);重度组患儿BALF中CD4+T/CD8+T比值低于轻中度组(P<0.05).两组移植前肺功能、胸部高分辨率CT和移植方式差异均无统计学意义(P均>0.05).多因素分析显示合并中重度慢性移植物抗宿主病(chronic graft-versus-host disease,cGVHD)(OR=14.302,95%CI:1.103~185.435)与儿童HSCT后发生重度NIPC有关,BALF中CD8+T淋巴细胞水平升高(OR=1.107,95%CI:1.107~1.204)是儿童HSCT后发生重度NIPC的独立危险因素(P<0.05).结论 合并中重度cGVHD与儿童HSCT后发生重度NIPC有关,BALF中CD8+T淋巴细胞升高是HSCT后出现NIPC的患儿进展至重度NIPC的独立风险因素,对于这部分患儿应高度警惕,尽早干预改善预后.
Background Non-infectious pulmonary complications(NIPC)after hematopoietic stem cell transplantation(HSCT)in children have an insidious onset,and are usually difficult to diagnose in the early stage.Also,these disorders are prone to progressing into a severe condition with poor therapeutic effect.Objective To explore the risk factors for severe NIPC after HSCT in children,providing a reference for the clinical diagnosis and management of pediatric NIPC.Design Case-control study.Methods Children who developed NIPC after HSCT at the children's medical center of Sun Yat-sen Memorial Hospital of Sun Yat-sen University from May 1,2020,to December 31,2023,aged under 16 years,underwent bronchoalveolar lavage fluid(BALF)immunological examination were enrolled.Exclude cases with NIPC caused by drugs or other factors as well as substandard quality of pulmonary function testing.Based on the degree of ventilatory dysfunction at the time of NIPC diagnosis,the children were divided into a mild-to-moderate group and a severe group.Clinical data of the children such as the general information,transplantation-related data,and BALF immunological indicators were collected via the hospital electronic medical record system.Influencing factors for severe NIPC outcomes in children undergoing HSCT were analyzed through univariate and multivariate analysis.Main Outcome Measures Influencing factors for severe NIPC outcomes in children undergoing HSCT.Results A total of 25 children with NIPC after HSCT were finally included in this study,with 14(56.0%)assigned to the mild-to-moderate group and 11(44.0%)to the severe group.Among them,22 cases(88.0%)manifested with bronchiolitis obliterans syndrome(BOS),3 cases(12.0%)presented with pulmonary fibrosis,and 4 cases(16.0%)were complicated by pneumothorax,pneumomediastinum,or subcutaneous emphysema.The univariate analysis showed that interleukin(IL)-8,IL-17A and CD8+T lymphocyte levels in the BALF of the mild-to-moderate group were significantly lower than that in the severe group(P<0.05),while CD4+T lymphocyte/CD8+T lymphocyte ratio in the BALF of the severe group was significantly lower than those in the mild-to-moderate group group(P<0.05).No statistically significant difference was observed in terms of pre-transplant pulmonary function,chest high resolution computed tomography findings,and transplantation methods between the two groups(all P>0.05).Also,the multivariable analysis indicated that the development of moderate-to-severe chronic graft-versus-host disease(cGVHD)(OR=14.302,95%CI:1.103-185.435)was related to the progression into severe NIPC after HSCT in children,and up-regulation of CD8+T lymphocyte in BALF(OR=1.107,95%CI:1.107-1.204)was identified as independent risk factor for severe NIPC following pediatric HSCT(P<0.05).Conclusion The development of moderate-to-severe cGVHD is related to the progression into severe NIPC after HSCT in children,and up-regulation of CD8+T lymphocyte in BALF is an independent risk factor for progressing into a severe condition in children with NIPC following HSCT.Great attention should be paid to these pediatric patients and early intervention is recommended to improve prognosis.
杨榷;黎丹华;王海燕;陈晗;吴葆菁;黄科;黄花荣
中山大学孙逸仙纪念医院儿童医学中心 广州,510120中山大学孙逸仙纪念医院儿童医学中心 广州,510120中山大学孙逸仙纪念医院儿童医学中心 广州,510120中山大学孙逸仙纪念医院儿童医学中心 广州,510120中山大学孙逸仙纪念医院儿童医学中心 广州,510120中山大学孙逸仙纪念医院儿童医学中心 广州,510120中山大学孙逸仙纪念医院儿童医学中心 广州,510120
儿童异基因造血干细胞移植非感染性肺部并发症免疫状态
ChildHematopoietic stem cell transplantationNon-infectious pulmonary complicationsImmune status
《中国循证儿科杂志》 2026 (4)
273-278,6
评论